IRF7 and neoplasm: Restoration of BCL7A hindered cell proliferation in competition cell growth assay and xenograft tumor formation in vivo modulating significantly the expression of genes such as HMGCS1, H1-0, and IRF7, which may help to explain its tumor suppressor role in AML.